Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study [Phase 3]

View source ↗

Summary

Phase 3 FUJI study assessing the safety and efficacy of DE-117 in primary open-angle glaucoma or ocular hypertension patients who are non- or low-responders to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-117

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Primary Open Angle Glaucoma or Ocular Hypertension | Phase 3 | Status: COMPLETED